Picture of Fusion Pharmaceuticals logo

FUSN — Fusion Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Fusion Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

* Fusion Pharmaceuticals Inc  FUSN.OQ  reported a quarterly
adjusted loss of 39 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -55 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 34 cents per
share. Wall Street expected results to range from -42 cents
to -27 cents per share.
    * Reported revenue was zero​; analysts expected $409.90
thousand. 
    * Fusion Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 39 cents​.
    * The company reported a quarterly loss of $28.18 million.
    * Fusion Pharmaceuticals Inc shares had risen by 120.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 9
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Fusion
Pharmaceuticals Inc is $21.00 
This summary was machine generated from LSEG data March 20 at
08:50 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.34          -0.39          Missed
 Sep. 30 2023      -0.40          -0.25          Beat
 Jun. 30 2023      -0.39          -0.38          Beat
 Mar. 31 2023      -0.32          -0.45          Missed

Recent news on Fusion Pharmaceuticals

See all news